Repositorio Dspace

Inflammatory biomarkers and plasma lipidomics after raltegravir plus TDF/FTC initiation in people with HIV: A longitudinal pilot study.

Mostrar el registro sencillo del ítem

dc.contributor.author Blanco, José-Ramon
dc.contributor.author Bernal-Morell, Enrique
dc.contributor.author Moreno, Santiago
dc.contributor.author Rial-Crestelo, David
dc.contributor.author Martínez-Vives, María
dc.contributor.author Alonso, Cristina
dc.contributor.author Pérez-Latorre, Leire
dc.contributor.author Reus-Banuls, Sergio
dc.contributor.author Romero, Lourdes
dc.contributor.author Ortiz-de-Barron, Xabier-Camino
dc.contributor.author Pérez-Martínez, Laura
dc.date.accessioned 2026-11-11T09:05:32Z
dc.date.available 2026-11-11T09:05:32Z
dc.date.issued 2026-10-19
dc.identifier.citation Blanco JR, Bernal-Morell E, Moreno S, Rial-Crestelo D, Martínez-Vives M, Alonso C, et al. Inflammatory biomarkers and plasma lipidomics after raltegravir plus TDF/FTC initiation in people with HIV: A longitudinal pilot study. Biomol Biomed. 19 de octubre de 2026. doi:10.17305/bb.2026.14928
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/29174
dc.description.abstract Persistent inflammation and altered lipid metabolism are linked to comorbidities in people with human immunodeficiency virus (HIV), yet their progression after initiating antiretroviral therapy (ART) is not fully understood. This exploratory, uncontrolled pilot study investigated longitudinal changes in biomarkers and plasma lipidomics in 11 ART-naïve adults starting raltegravir plus tenofovir disoproxil fumarate/emtricitabine. Circulating biomarkers were measured, and untargeted plasma lipidomics was performed using ultra-high-performance liquid chromatography-mass spectrometry at baseline and at a follow-up visit near week 48 (range: 47.7-61.9 weeks). Within-participant changes were analyzed using paired Wilcoxon signed-rank tests, with Benjamini-Hochberg false discovery rate (FDR) correction applied separately to biomarker and lipidomic datasets. Paired effect sizes and 95% confidence intervals were also estimated. All participants achieved virological suppression. After FDR correction, interleukin-10 (IL-10) concentrations increased, and soluble cluster of differentiation 163 (sCD163) concentrations decreased (both q = 0.019). However, none of the 490 lipid features remained significant after FDR correction. Twenty-six features showed large absolute paired Hedges' effect-size estimates (|gz| ? 0.80), with 24 positive and two negative estimates. These findings demonstrate longitudinal changes in IL-10 and sCD163 following ART initiation. The lipidomic results, however, are considered hypothesis-generating. Due to the absence of a comparator group, these changes cannot be definitively attributed to the specific ART regimen. Larger, controlled studies are necessary to confirm reproducibility and clinical relevance.
dc.language.iso eng
dc.publisher ASSOCIATION OF BASIC MEDICAL SCIENCES OF FBIH
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.title Inflammatory biomarkers and plasma lipidomics after raltegravir plus TDF/FTC initiation in people with HIV: A longitudinal pilot study.
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 42895462
dc.relation.publisherversion https://bjbms.org/ojs/index.php/bjbms/article/view/14928
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.17305/bb.2026.14928
dc.journal.title Biomolecules & Biomedicine
dc.identifier.essn 2831-090X


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta